NewAmsterdam Pharma Company N.V. (NAMS)

NASDAQ: NAMS · Real-Time Price · USD

30.41

-2.42 (-7.39%)

At close: Mar 3, 2026, 4:00 PM EST

31.48

+1.07 (3.54%)

Pre-market: Mar 4, 2026, 6:31 AM EST

NAMS Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	490	771.74	340.45	470.39	60.37
Short-Term Investments	146.24	62.45	-	-	-
Cash & Short-Term Investments	636.24	834.19	340.45	470.39	60.37
Cash Growth	-23.73%	145.03%	-27.62%	679.14%	530.62%
Other Receivables	-	4.95	-	-	-
Total Trade Receivables	-	4.95	-	-	-
Other Current Assets	39.46	24.27	6.34	10.31	6.57
Total Current Assets	675.7	863.41	346.79	480.7	66.95
Net Property, Plant & Equipment	0.57	0.67	0.1	0.15	0.22
Other Intangible Assets	0.41	0.53	88.7	89.2	-
Long-Term Investments	92.61	-	-	-	-
Other Long-Term Assets	-	-	0.04	0.16	0.82
Total Assets	769.28	864.62	435.62	570.22	67.98
Accounts Payable	8.97	4.74	16.92	19.85	11.17
Accrued Expenses	15.42	13.61	14.88	-	-
Current Portion of Leases	0.14	0.25	0.06	0.07	0.06
Unearned Revenue	3.99	6.01	8.94	13.95	-
Other Current Liabilities	57.27	82.31	12.57	4.17	-
Total Current Liabilities	85.79	106.92	53.38	38.04	11.23
Long-Term Leases	0.07	0.2	-	0.06	0.13
Other Long-Term Liabilities	-	-	8.81	12.38	-
Total Long-Term Liabilities	0.07	0.2	8.81	12.44	0.13
Total Liabilities	85.85	107.12	62.18	50.48	11.36
Common Stock	14.28	13.44	10.17	642.74	95.38
Additional Paid-in Capital	1,427	1,298	641.21	-	-
Accumulated Other Comprehensive Income	4.79	4.47	30.04	5.03	0.67
Retained Earnings	-762.39	-558.57	-307.98	-128.04	-39.43
Total Common Shareholders' Equity	683.43	757.5	373.44	519.73	56.62
Shareholders' Equity	683.43	757.5	373.44	519.73	56.62
Total Liabilities & Equity	769.28	864.62	435.62	570.22	67.98
Total Debt	0.2	0.45	0.06	0.13	0.19
Net Cash (Debt)	636.04	833.74	340.39	470.26	60.19
Net Cash Growth	-23.71%	144.94%	-27.62%	681.34%	-
Net Cash Per Share	5.37	8.84	4.14	24.80	2.55
Book Value	683.43	757.5	373.44	519.73	56.62
Book Value Per Share	5.77	8.03	4.55	27.40	2.40
Tangible Book Value	683.02	756.97	284.74	430.53	56.62
Tangible Book Value Per Share	5.77	8.02	3.47	22.70	2.40

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q